Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child

Sinan Sari, Guldal Yilmaz, Ipek I. Gonul, Buket Dalgic, Gulen Akyol, Isabella Giovannoni, Paola Francalanci, Francesco Callea

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background and Aims: Fibrinogen gene mutations can rarely result in hepatic fibrinogen storage disease (HFSD). Herein, we report on the first Turkish family carrying the mutation p.Arg375Trp (fibrinogen Aguadilla) in the γ-chain of the fibrinogen (FGG) gene. Methods: Clinical, laboratory and histopathological findings of the patient were documented. Molecular study of fibrinogen gene was performed in the patient and her family members. Results: The proband was 5 years old girl presenting with advanced liver fibrosis of unknown origin. The child had very low plasma levels of fibrinogen and hypobetalipoproteinemia. Immunomorphologic and electron microscopic studies showed selective and exclusive accumulation of fibrinogen within the endoplasmic reticulum in liver biopsy of the patient. Patient, mother, two sisters and one brother carried p.Arg375Trp mutation (fibrinogen Aguadilla) in FGG gene. The patient was treated with ursodeoxycholic acid and carbamazepine. After 3 months, carbamazepine was suspended upon family decision and unresponsiveness of carbamazepine. Conclusions: HFSD is characterized by hypofibrinogenemia and accumulation of abnormal fibrinogen within hepatocytes. In addition, hypofibrinogenemia is associated with hypobetalipoproteinemia in Aguadilla mutation.

Original languageEnglish
Pages (from-to)2501-2505
Number of pages5
JournalLiver International
Volume35
Issue number12
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Hypobetalipoproteinemias
Fibrinogen
Fibrosis
Carbamazepine
Mutation
Genes
Siblings
Liver
Abnormal Fibrinogens
Ursodeoxycholic Acid
Endoplasmic Reticulum
Liver Cirrhosis
Hepatocytes
Mothers

Keywords

  • Child
  • Cirrhosis
  • Fibrinogen Aguadilla
  • Fibrinogen storage disease
  • Hypobetalipoproteinemia

ASJC Scopus subject areas

  • Hepatology

Cite this

Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child. / Sari, Sinan; Yilmaz, Guldal; Gonul, Ipek I.; Dalgic, Buket; Akyol, Gulen; Giovannoni, Isabella; Francalanci, Paola; Callea, Francesco.

In: Liver International, Vol. 35, No. 12, 01.12.2015, p. 2501-2505.

Research output: Contribution to journalArticle

@article{56e350ac38314008b00144ec8fe971a9,
title = "Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child",
abstract = "Background and Aims: Fibrinogen gene mutations can rarely result in hepatic fibrinogen storage disease (HFSD). Herein, we report on the first Turkish family carrying the mutation p.Arg375Trp (fibrinogen Aguadilla) in the γ-chain of the fibrinogen (FGG) gene. Methods: Clinical, laboratory and histopathological findings of the patient were documented. Molecular study of fibrinogen gene was performed in the patient and her family members. Results: The proband was 5 years old girl presenting with advanced liver fibrosis of unknown origin. The child had very low plasma levels of fibrinogen and hypobetalipoproteinemia. Immunomorphologic and electron microscopic studies showed selective and exclusive accumulation of fibrinogen within the endoplasmic reticulum in liver biopsy of the patient. Patient, mother, two sisters and one brother carried p.Arg375Trp mutation (fibrinogen Aguadilla) in FGG gene. The patient was treated with ursodeoxycholic acid and carbamazepine. After 3 months, carbamazepine was suspended upon family decision and unresponsiveness of carbamazepine. Conclusions: HFSD is characterized by hypofibrinogenemia and accumulation of abnormal fibrinogen within hepatocytes. In addition, hypofibrinogenemia is associated with hypobetalipoproteinemia in Aguadilla mutation.",
keywords = "Child, Cirrhosis, Fibrinogen Aguadilla, Fibrinogen storage disease, Hypobetalipoproteinemia",
author = "Sinan Sari and Guldal Yilmaz and Gonul, {Ipek I.} and Buket Dalgic and Gulen Akyol and Isabella Giovannoni and Paola Francalanci and Francesco Callea",
year = "2015",
month = "12",
day = "1",
doi = "10.1111/liv.12914",
language = "English",
volume = "35",
pages = "2501--2505",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "12",

}

TY - JOUR

T1 - Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child

AU - Sari, Sinan

AU - Yilmaz, Guldal

AU - Gonul, Ipek I.

AU - Dalgic, Buket

AU - Akyol, Gulen

AU - Giovannoni, Isabella

AU - Francalanci, Paola

AU - Callea, Francesco

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background and Aims: Fibrinogen gene mutations can rarely result in hepatic fibrinogen storage disease (HFSD). Herein, we report on the first Turkish family carrying the mutation p.Arg375Trp (fibrinogen Aguadilla) in the γ-chain of the fibrinogen (FGG) gene. Methods: Clinical, laboratory and histopathological findings of the patient were documented. Molecular study of fibrinogen gene was performed in the patient and her family members. Results: The proband was 5 years old girl presenting with advanced liver fibrosis of unknown origin. The child had very low plasma levels of fibrinogen and hypobetalipoproteinemia. Immunomorphologic and electron microscopic studies showed selective and exclusive accumulation of fibrinogen within the endoplasmic reticulum in liver biopsy of the patient. Patient, mother, two sisters and one brother carried p.Arg375Trp mutation (fibrinogen Aguadilla) in FGG gene. The patient was treated with ursodeoxycholic acid and carbamazepine. After 3 months, carbamazepine was suspended upon family decision and unresponsiveness of carbamazepine. Conclusions: HFSD is characterized by hypofibrinogenemia and accumulation of abnormal fibrinogen within hepatocytes. In addition, hypofibrinogenemia is associated with hypobetalipoproteinemia in Aguadilla mutation.

AB - Background and Aims: Fibrinogen gene mutations can rarely result in hepatic fibrinogen storage disease (HFSD). Herein, we report on the first Turkish family carrying the mutation p.Arg375Trp (fibrinogen Aguadilla) in the γ-chain of the fibrinogen (FGG) gene. Methods: Clinical, laboratory and histopathological findings of the patient were documented. Molecular study of fibrinogen gene was performed in the patient and her family members. Results: The proband was 5 years old girl presenting with advanced liver fibrosis of unknown origin. The child had very low plasma levels of fibrinogen and hypobetalipoproteinemia. Immunomorphologic and electron microscopic studies showed selective and exclusive accumulation of fibrinogen within the endoplasmic reticulum in liver biopsy of the patient. Patient, mother, two sisters and one brother carried p.Arg375Trp mutation (fibrinogen Aguadilla) in FGG gene. The patient was treated with ursodeoxycholic acid and carbamazepine. After 3 months, carbamazepine was suspended upon family decision and unresponsiveness of carbamazepine. Conclusions: HFSD is characterized by hypofibrinogenemia and accumulation of abnormal fibrinogen within hepatocytes. In addition, hypofibrinogenemia is associated with hypobetalipoproteinemia in Aguadilla mutation.

KW - Child

KW - Cirrhosis

KW - Fibrinogen Aguadilla

KW - Fibrinogen storage disease

KW - Hypobetalipoproteinemia

UR - http://www.scopus.com/inward/record.url?scp=84983134491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983134491&partnerID=8YFLogxK

U2 - 10.1111/liv.12914

DO - 10.1111/liv.12914

M3 - Article

VL - 35

SP - 2501

EP - 2505

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 12

ER -